Tag:

Pneumovax

Latest Headlines

Latest Headlines

Lupin eyes vaccine growth after in-licensing Merck shot

Merck is the latest company to decide its interests in India are best served by licensing a product to a local business. The drugmaker has signed a nonexclusive outlicensing deal for its 23-valent pneumococcal vaccine with Indian firm Lupin.

20 Top-selling Vaccines-- H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales.

The 20 top-selling vaccines in H1 2012

As H1 came to a close, FierceVaccines decided to take a look at which prophylactic vaccines flew off the shelves--and which companies made the sales. Take a look at the full list >>

FDA staffers back Pfizer's Prevnar vax for adults

Will Pfizer ($PFE) succeed at broadening use of its star vaccine? A report from FDA reviewers suggest it might. In a pre-advisory committee review, agency staffers said the Prevnar 13 vaccine was

Charred shrink wrap detected in Merck vax vials

The latest snafu at Merck's West Point, PA, vaccines plant shows just how tough it can be to fix manufacturing problems once they begin. After a series of quality-control issues and reporting

Flu could goose Pneumovax sales

We know that antiviral drugmakers Roche and GlaxoSmithKline are reaping big sales from the H1N1 swine flu pandemic. And that vaccine makers--including Glaxo, Sanofi-Aventis, Baxter, and more--are,